The multi-structural feature of the multidrug resistance gene product P-glycoprotein: implications for its mechanism of action

References

• Beja, O. and Bibi, E., 1995, Multidrug resistance protein (Mdr)- alkaline phosphatas e hybrids in Escherichia coli suggest a major revision in the topology of the C-terminal half of Mdr. Journal of Biological Chemistry, 270, 12351 ± 12354.
   PubMedGoogle Scholar
• Bibi, E. and Beja, O., 1994, Membrane topology of multidrugresistance protein express ed in E scherichia coli. N-terminal domain. Journal of Biological Chemistry, 269, 19910 ± 19915.
   PubMedGoogle Scholar
• Blobel, G., 1980, Intracellula r protein topogenesis. Proceedings of the National Academy of Sciences (USA), 77, 1496 ± 1500.
   PubMed Web of Science ®Google Scholar
• Borel, A. C. and Simon, S. M., 1996, Biogenesis of polytopic membrane proteins: membrane s egments ass emble within translocation channels prior to membrane integration. Cell, 85, 379 ± 389.
   PubMedGoogle Scholar
• Bruggemann, E. P., Germann, U. A., Gottesman, M. M. and Pastan,I., 1989, Two different regions of P-glycoprotein are photoaffinity- labeled by azidopine. Journal of Biological Chemistry, 264, 15483 ± 15488.
   PubMed Web of Science ®Google Scholar
• Buschman, E., Arceci, R J., Croop, J. M., Che, M., Arias, I. M., Housman, D. E. and Gros, P., 1992, mdr2 encodes P-glycoprotein expressed in the bile canalicula r membrane as determined by isoform-specific antibodies. Journal of Biological Chemistry, 267, 18093 ± 18099.
   PubMed Web of Science ®Google Scholar
• Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M. and Roninson, I. B., 1986, Internal duplication and homology with bacteria l transport proteins in the mdr1 (P- glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381 ± 389.
   PubMed Web of Science ®Google Scholar
• Childs, S., Yeh, R. L., Georges, E. and Ling, V., 1995, Identifica tion of a sister gene to P-glycoprotein. Cancer Res earch, 55, 2029 ± 2034.
   PubMed Web of Science ®Google Scholar
• Choi, K., Chen, C.-J., Kriegler, M. and Roninson, I. B., 1988, An altered pattern of cross-resistanc e in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P- glycoprotein) gene. Cell, 53, 519 ± 529.
   Google Scholar
• Cianfriglia, M., Willingham, M. C., Tombes, M., Scagliotti, G. V., Frasca, G. and Chersi, A., 1994, P-glycoprotein epitope mapping.I. Identifica tion of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellula r domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. Interna- tional Journal of Cancer, 56, 153 ± 160.
   PubMedGoogle Scholar
• Demmer, A., Thole, H., Kubesch, P., Brandt, T., Raida, M., Fislage,R. and Tummler, B., 1997, Localization of the iodomycin binding site in hamster P-glycoprotein. Journal of Biologica l Chemistry, 272, 20913 ± 20919.
   PubMedGoogle Scholar
• Doige, C. A. and Aymes, G. F., 1993, ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annual Review of Microbiology, 47, 291 ± 319.
   PubMed Web of Science ®Google Scholar
• Georges, E., Tsuruo, T. and Ling, V., 1993, Topology of P- glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. Journal of Biological Chemistry, 268, 1792 ± 1798.
   PubMed Web of Science ®Google Scholar
• Gerlach, J. H., Endicott, J. A., Juranka, P. F., Henderson, G., Sarangi, F., Deuchars, K. L. and Ling, V., 1986, Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature, 324, 485 ± 489.
   PubMed Web of Science ®Google Scholar
• Gottesman, M. M. and Pastan, I., 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385 ± 427.
   PubMed Web of Science ®Google Scholar
• Greenberger, L. M., 1993, Major photoaffinity drug labeling sites foriodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. Journal of Biologica l Chemistry, 268, 11417 ± 11425.
   PubMedGoogle Scholar
• Gros, P., Croop, J. and Housman, D., 1986, Mammalian multidrug resistance gene: complete cDNA s equence indicates strong homology to bacterial transport proteins. Cell, 47, 371 ± 380.
   PubMed Web of Science ®Google Scholar
• Han, E. S. and Zhang, J. T., 1998, Mechanism involved in generating the carboxyl-terminal half topology of P-glycoprotein. Biochem- istry, 37, 11996 ± 12004.
   PubMedGoogle Scholar
• Han, E. S. and Zhang, J. T., 1999, Membrane orientation of carboxyl- terminal half P-glycoprotein: topogenesis of transmembrane s egments. European Journal of Cell Biology, 78, 624 ± 631.
   PubMedGoogle Scholar
• Hartmann, E., Rapoport, T. A. and Lodish, H. F., 1989, Predicting the orientation of eukaryotic membrane-spanning proteins. Proceed- ings of the National Academy of Sciences (USA), 86, 5786 ± 5790.
   PubMed Web of Science ®Google Scholar
• Higgins, C. F., 1992, ABC transporters: from microorganisms to man. Annual Review of Cell Biology, 8, 67 ± 113.
   PubMedGoogle Scholar
• Juliano, R. L. and Ling, V., 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta, 455, 152 ± 162.
   PubMed Web of Science ®Google Scholar
• Juranka, P. F., Zastawny, R. L. and Ling, V., 1989, P-glycoprotein: multidrug-resistanc e and a superfamily of membrane-associated transport proteins. FASEB Journal, 3, 2583 ± 2592.
   PubMed Web of Science ®Google Scholar
• Kast, C., Canfield, V., Levenson, R. and Gros, P., 1995, Membranetopology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-termina l domain of mdr3. Biochemistry, 34, 4402 ± 4411.
   PubMedGoogle Scholar
• Kast, C., Canfield, V., Levenson, R. and Gros, P., 1996, Transmem- brane organization of mouse P-glycoprotein determined by epitope ins ertion and immunofluorescence. Journal of Biological Chemistry, 271, 9240 ± 9248.
   PubMed Web of Science ®Google Scholar
• Klein, I., Sarkadi, B. and Varadi, A., 1999, An inventory of the human ABC proteins. Biochimica et Biophysica Acta, 1461, 237 ± 262. Lipp, J., Flint, N., Haeuptle, M. T. and Dobberstein, B., 1989, Structural requirements for membrane ass embly of proteins spanning the membrane s everal times. Journal of Cell Biology, 109, 2013 ± 2022.
   Google Scholar
• Liu, R. and Sharom, F. J., 1996, Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry, 35, 11865 ± 11873.
   PubMed Web of Science ®Google Scholar
• Liu, R. and Sharom, F. J., 1997, Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter. Biochemistry, 36, 2836 ± 2843.
   PubMedGoogle Scholar
• Liu, R. and Sharom, F. J., 1998, Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study. Biochem- istry, 37, 6503 ± 6512.
   PubMedGoogle Scholar
• Liu, R., Siemiarczuk, A. and Sharom, F. J., 2000, Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitiv- ity of tryptophan residues to binding of drugs and nucleotides. Biochemistry, 39, 14927 ± 14938.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M., 1993a, Functional cons equences ofphenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. Journal of Biologica l Chemistry, 268, 19965 ± 19972.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M., 1993b, Functional cons equences of proline mutations in the predicted transmembrane domain of P- glycoprotein. Journal of Biological Chemistry, 268, 3143 ± 3149.
   PubMedGoogle Scholar
• Loo, T. W. and Clarke, D. M., 1995, Membrane topology of a cysteine-les s mutant of human P-glycoprotein. Journal of Biolo- gical Chemistry, 270, 843 ± 848.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M.1997, Identifica tion of residues in the drug-binding site of human P- glycoprotein using a thiol-reactiv e substrate. Journal of Biologica l Chemistry, 272, 31945 ± 31948.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M., 1999a, The glycosylation and orientation in the membrane of the third cytoplasmic loop of human P-glycoprotein is affected by mutations and substrates. Biochemistry, 38, 5124 ± 5129.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M., 1999b, Identifica tion of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane. Journal of Biological Chemistry, 274, 35388 ± 35392.
   PubMed Web of Science ®Google Scholar
• Loo, T. W. and Clarke, D. M., 2000, Identifica tion of residues within the drug-binding domain of the human multidrug resistance P- glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane. Journal of Biological Chemistry, 275, 39272 ± 39278.
   Google Scholar
• Mechetner, E. B., Schott, B., Mors e, B. S., Stein, W. D., Druley, T., Davis, K. A., Tsuruo, T. and Roninson, I. B., 1997, P-glycoprotein function involves conformational transitions detectable by differ- ential immunoreactivity. Proceedings of the National Academy of Sciences (USA), 94, 12908 ± 12913.
   Google Scholar
• Morris, D. I., Greenberger, L. M., Bruggemann, E. P., Cardarelli, C., Gottesman, M. M., Pastan, I. and Seamon, K. B., 1994, Localization of the forskolin labeling sites to both halves of P- glycoprotein: similarity of the sites labeled by forskolin and prazosin. Molecula r Pharmacology, 46, 329 ± 337.
   PubMedGoogle Scholar
• Ng, W. F., Sarangi, F., Zastawny, R. L., Veinot-Drebot, L. and Ling, V., 1989, Identification of members of the P-glycoprotein multi- gene family. Molecula r and Cellular Biology, 9, 1224 ± 1232.
   PubMed Web of Science ®Google Scholar
• Pawagi, A. B., Wang, J., Silverman, M., Reithmeier, R. A. F. andCeber, C. M., 1994, Transmembrane aromatic amino acid distribution in P-glycoprotein. Journal of Molecula r Biology, 235, 554 ± 564.
   PubMed Web of Science ®Google Scholar
• Richert, N. D., Aldwin, L., Nitecki, D., Gottesman, M. M. and Pastan, I., 1988, Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry, 27, 7607 ± 7613.
   PubMed Web of Science ®Google Scholar
• Roepe, P. D., Wei, L. Y., Cruz, J. and Carlson, D., 1993, Lower electrica l membrane potentia l and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterizatio n of a s eries of MDR cell lines expressing different levels of P- glycoprotein. Biochemistry, 32, 11042 ± 11056.
   PubMed Web of Science ®Google Scholar
• Romagnoli, G., Poloni, F., Flego, M., Moretti, F., Di Modugno, F., Chersi, A., Falasca, G., Signoretti, C., Castagna, M. and Cianfriglia, M., 1999, Epitope mapping of the monoclonal antibody MM12.10 to external MDR1 P-glycoprotein domain by synthetic peptide scanning and phage display technologies. Biological Chemistry, 380, 553 ± 559.
   PubMedGoogle Scholar
• Rosenberg, M. F., Callaghan, R., Ford, R. C. and Higgins, C. F., 1997, Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. Journal of Biologica l Chemistry, 272, 10685 ± 10694.
   PubMed Web of Science ®Google Scholar
• Ruetz, S. and Gros, P., 1994, Phosphatidylcholine translocas e: a physiological role for the mdr2 gene. Cell, 77, 1071 ± 1081.
   PubMed Web of Science ®Google Scholar
• Seelig, A., 1998, A general pattern for substrate recognition by P- glycoprotein. European Journal of Biochemistry, 251, 252 ± 261.
   PubMedGoogle Scholar
• Senior, A. E., al-Shawi, M. K. and Urbatsch, I. L., 1995, The catalytic cycle of P-glycoprotein. FEBS Letters, 377, 285 ± 289.
   Google Scholar
• Shapiro, A. B., Corder, A. B. and Ling, V., 1997, P-glycoprotein- mediated Hoechst 33342 transport out of the lipid bilayer. European Journal of Biochemistry, 250, 115 ± 121.
   PubMedGoogle Scholar
• Shapiro, A. B., Duthie, M., Childs, S., Okubo, T. and Ling, V., 1996,Characterization and epitope mapping of s evera l new anti-P- glycoprotein monoclonal antibodies. Internationa l Journal of Cancer, 67, 256 ± 263.
   Google Scholar
• Sharom, F. J., Liu, R., Romsicki, Y. and Lu, P., 1999, Insights into the structur e and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochimica et Biophysica Acta, 1461, 327 ± 345.
   PubMed Web of Science ®Google Scholar
• Simon, S. M., Blobel, G. and Zimmerberg, J., 1989, Large aqueous channels in membrane vesicles derived from the rough endo- plasmic reticulum of canine pancreas or the plasma membrane of Escherichia coli. Proceedings of the National Academy of Sciences (USA), 86, 6176 ± 6180.
   Google Scholar
• Skach, W. R. and Lingappa, V. R., 1993a, Amino-termina l ass embly of human P-glycoprotein at the endoplasmic reticulum is directed by cooperative actions of two internal s equences. Journal of Biological Chemistry, 268, 23552 ± 23561.
   PubMedGoogle Scholar
• Skach, W. R. and Lingappa, V. R., 1993b, In Intracellula r traffickin g of pre- (pro) proteins across RER membrane, Y. Peng Loh, ed. (Boca Raton, FL: CRC Press Inc), pp. 19 ± 77.
   Google Scholar
• Skach, W. R. and Lingappa, V. R., 1994, Transmembrane orientation and topogenesis of the third and fourth membrane-spanning regions of human P-glycoprotein (MDR1). Cancer Research, 54, 3202 ± 3209.
   PubMedGoogle Scholar
• Skach, W. R., Calayag, M. C. and Lingappa, V. R., 1993, Evidence for an alternate model of human P-glycoprotein structure and biogenesis. Journal of Biological Chemistry, 268, 6903 ± 6908.
   PubMedGoogle Scholar
• Smit, J. J., Schinkel, A. H., Oude Elferink, R. P., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A., Ottenhoff, R., van der Lugt, N. M., van Roon, M. A., van der Valk, M. A., Offerhaus, G. J. A., Berns, A. J. M. and Borst, P., 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete abs ence of phospholipid from bile and to liver dis eas e. Cell, 75, 451±462.
   PubMedGoogle Scholar
• Sonveaux, N., Shapiro, A. B., Goormaghtigh, E., Ling, V. and Ruysscha ert, J. M., 1996, Secondary and tertiary structure changes of reconstituted P-glycoprotein. A Fourier transform attenuated total reflection infrared spectroscopy analysis. Journal of Biologica l Chemistry, 271, 24617 ± 24624.
   Google Scholar
• Sonveaux, N., Vigano, C., Shapiro, A. B., Ling, V. and Ruysscha ert,J. M., 1999, Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein. A tryptophan fluorescence quench- ing analysis. Journal of Biologica l Chemistry, 274, 17649 ± 17654. Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I., 1987, Expression of a full-length cDNA for the human `MDR1’ gene confers resistance to colchicine, doxorubicin, and vinblastine. Proceedings of the National Academy of Sciences (USA), 84,3004 ± 3008.
   Google Scholar
• Wang, C., Chen, M., Han, E. and Zhang, J. T., 1997a, Role of ribosomes in reinitiation of membrane insertion of internal transmembrane s egments in a polytopic membrane protein. Biochemistry, 36, 11437 ± 11443.
   PubMedGoogle Scholar
• Wang, G., Pincheira, R. and Zhang, J. T., 1998, Diss ection of drug- binding-induced conformational changes in P-glycoprotein. Eur- opean Journal of Biochemistry, 255, 383 ± 390.
   PubMedGoogle Scholar
• Wang, G., Pincheira, R., Zhang, M. and Zhang, J. T., 1997b, Conformational changes of P-glycoprotein by nucleotide binding. Biochemistry Journal, 328, 897 ± 904.
   PubMedGoogle Scholar
• Wess els, H. P. and Spiess, M., 1988, Ins ertion of a multispanning membrane protein occurs s equentially and requires only one signal s equence. Cell, 55, 61 ± 70.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A., Kuwazuru, Y., Sumizawa, T., Ichikawa, M., Ikeda, S., Uda, T. and Akiyama, S., 1989, Cytoplasmic orientation and two- domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. Journal of Biological Chemistry, 264, 16282 ± 16291.
   PubMed Web of Science ®Google Scholar
• Zhang, J. T. and Ling, V., 1991, Study of membrane orientation and glycosylated extracellula r loops of mous e P-glycoprotein by in vitro translation. Journal of Biologica l Chemistry, 266, 18224 ± 18232.
   PubMedGoogle Scholar
• Zhang, J. T. and Ling, V., 1993, Membrane orientation of transmembrane s egments 11 and 12 of MDR- and non-MDR- associated P-glycoproteins. Biochimica et Biophysica Acta, 1153, 191 ± 202.
   PubMedGoogle Scholar
• Zhang, J. T. and Ling, V., 1995, Involvement of cytoplasmic factors regulating the membrane orientation of P-glycoprotein sequences. Biochemistry, 34,9159 ± 9165.
   Google Scholar
• Zhang, J. T., Chen, M., Han, E. and Wang, C., 1998, Diss ection of de novo membrane ins ertion activitie s of internal transmembrane s egments of ATP-binding-cass ette transporters: toward under- standing topological rules for membrane ass embly of polytopic membrane proteins. Molecular Biology of the Cell, 9, 853 ± 863.
   PubMedGoogle Scholar
• Zhang, J. T., Duthie, M. and Ling, V., 1993, Membrane topology of the N-termina l half of the hamster P-glycoprotein molecule. Journal of Biologica l Chemistry, 268, 15101 ± 15110.
   PubMedGoogle Scholar
• Zhang, J. T., Han, E. and Liu, Y., 2000, Role of the ribosome in s equence-specific regulation of membrane targeting and translo- cation of P-glycoprotein signal-anchor transmembrane segments. Journal of Cell Science, 113, 2545 ± 2555.
   PubMedGoogle Scholar
• Zhang, J. T., Lee, C. H., Duthie, M. and Ling, V., 1995, Topological determinants of internal transmembrane s egments in P-glycopro- tein sequences. Journal of Biological Chemistry, 270, 1742 ± 1746.
   PubMedGoogle Scholar
• Zhang, M., Wang, G., Shapiro, A. and Zhang, J. T., 1996, Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug- transport mechanism. Biochemistry, 35, 9728 ± 9736.
   PubMedGoogle Scholar